Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Florida · 2025 Regular Session · Bill

HB 1617: Stem Cell Therapy

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 1617 is a bill introduced in the Florida House on February 28, 2025. According to its official title, it concerns: Stem Cell Therapy. Primary sponsor: James Buchanan (Republican), Health Professions & Programs Subcommittee, Health & Human Services Committee. It lists 1 additional sponsor. Most recent recorded action (April 30, 2025): Laid on Table, companion bill(s) passed, see CS/CS/SB 1768 (Ch. 2025-185).

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Stem Cell Therapy ; Authorizes allopathic physicians & osteopathic physicians to perform stem cell therapy not approved by United States Food & Drug Administration; specifies requirements for stem cells that may be used by allopathic physicians & osteopathic physicians; requires allopathic physicians & osteopathic physicians to adhere to applicable current good manufacturing practices in performance of such therapies; prohibits allopathic physicians & osteopathic physicians from obtaining stem cells for therapies from facilities failing to meet certain requirements; requires allopathic physicians & osteopathic physicians to include certain terms in contracts or agreements with facilities producing stem cells for therapies; requires allopathic physicians & osteopathic physicians to include specified notice in any form of advertisement; provides requirements for such notice; requires allopathic physicians & osteopathic physicians to obtain signed consent form from patient or his or her representative before performing therapy; specifies requirements for consent form; requires Board of Medicine & Board of Osteopathic Medicine to adopt rules, respectively.

Sponsors

Sponsors by party (alphabetical): Republican 2

NameRolePartyChamberDistrict
James BuchananPrimary sponsorRepublicanHouse74
Health Professions & Programs SubcommitteePrimary sponsorNot applicable (committee)——
Health & Human Services CommitteePrimary sponsorNot applicable (committee)——
Dean BlackCo-sponsorRepublicanHouse15

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Laid on Table, companion bill(s) passed, see CS/CS/SB 1768 (Ch. 2025-185)
  2. Added to Second Reading Calendar
  3. Bill referred to House Calendar
  4. 1st Reading (Committee Substitute 2)
  5. CS Filed
  6. Laid on Table under Rule 7.18(a)
  7. Reported out of Health & Human Services Committee
  8. Favorable with CS by Health & Human Services Committee
  9. Added to Health & Human Services Committee agenda
  10. Now in Health & Human Services Committee
  11. Referred to Health & Human Services Committee
  12. 1st Reading (Committee Substitute 1)

Showing 12 most recent of 22 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source